ORACEA Capsules are precisely formulated for rapid and powerful results1
- In a clinical study, results were seen as early as week 3 and continued through week 161
- ORACEA Capsules can impact the inflammatory lesions of rosacea and did not induce bacterial resistance in a 9-month study1
The precise formulation of ORACEA Capsules, 30 mg immediate release and 10 mg delayed release beads, provide:
- Comparable efficacy to doxycycline 100 mg (an antibiotic dose)2
- No evidence of antimicrobial activity1
ORACEA Capsules Efficacy
ORACEA Capsules are uniquely formulated for early and sustained efficacy in treating the inflammatory lesions associated with rosacea.
ORACEA Capsules Tolerability
ORACEA Capsules have superior GI tolerability versus doxycycline 100 mg.2 ORACEA Capsules did not include symptoms of nausea, diarrhea, vomiting or abdominal pain.1,2